NO20074032L - Medisinleveringssystem - Google Patents

Medisinleveringssystem

Info

Publication number
NO20074032L
NO20074032L NO20074032A NO20074032A NO20074032L NO 20074032 L NO20074032 L NO 20074032L NO 20074032 A NO20074032 A NO 20074032A NO 20074032 A NO20074032 A NO 20074032A NO 20074032 L NO20074032 L NO 20074032L
Authority
NO
Norway
Prior art keywords
dose
prescribed
adjusted
drug
medicine container
Prior art date
Application number
NO20074032A
Other languages
English (en)
Inventor
Enrico Chavez
Vincent Pongpairochana
Sandrine Piotelat
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05003110A external-priority patent/EP1690559A1/en
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20074032L publication Critical patent/NO20074032L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
    • A61M2005/31518—Piston or piston-rod constructions, e.g. connection of piston with piston-rod designed to reduce the overall size of an injection device, e.g. using flexible or pivotally connected chain-like rod members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/13—General characteristics of the apparatus with means for the detection of operative contact with patient, e.g. lip sensor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/14—Detection of the presence or absence of a tube, a connector or a container in an apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or cartridges, e.g. automatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or cartridges, e.g. automatic
    • A61M5/2455—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or cartridges, e.g. automatic with sealing means to be broken or opened
    • A61M5/2466—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or cartridges, e.g. automatic with sealing means to be broken or opened by piercing without internal pressure increase

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Seal Device For Vehicle (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

En avleveringsinnretning for medisin som er utformet til å motta en utbyttbar medisinbeholder og å bestemme en justert medisindose AD før hver avlevering av medisinen inneholdt i medisinbeholderen hvis det inneværende innhold av medisinbeholderen ikke er et multippel av en foreskrevet dose D og er større enn den foreskrevne dose D. Den justerte medisindose AD er den dose som skal avleveres i stedet for den foreskrevne dose D i løpet av medisinavleveringen. Den justerte medisindose AD bestemmes ved å velge en av en første dose, som er høyere enn den foreskrevne dose D, og av en andre dose, som er lavere enn den foreskrevne dose D, som en funksjon av en variabel B som kumulerer verdiene (AD - D).
NO20074032A 2005-02-14 2007-08-03 Medisinleveringssystem NO20074032L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05003110A EP1690559A1 (en) 2005-02-14 2005-02-14 Medication delivery device
EP06000693A EP1690560A1 (en) 2005-02-14 2006-01-13 Medication delivery device
PCT/IB2006/000135 WO2006085175A1 (en) 2005-02-14 2006-01-27 Medication delivery device

Publications (1)

Publication Number Publication Date
NO20074032L true NO20074032L (no) 2007-11-14

Family

ID=36127528

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074032A NO20074032L (no) 2005-02-14 2007-08-03 Medisinleveringssystem

Country Status (19)

Country Link
US (1) US8137304B2 (no)
EP (2) EP1690560A1 (no)
JP (1) JP4971192B2 (no)
AT (1) ATE425782T1 (no)
AU (1) AU2006213538B2 (no)
CA (1) CA2596921C (no)
CY (1) CY1109152T1 (no)
DE (1) DE602006005810D1 (no)
DK (1) DK1885413T3 (no)
ES (1) ES2322716T3 (no)
HR (1) HRP20090183T1 (no)
IL (1) IL184878A0 (no)
ME (1) ME01094B (no)
NO (1) NO20074032L (no)
PL (1) PL1885413T3 (no)
PT (1) PT1885413E (no)
RS (1) RS50983B (no)
SI (1) SI1885413T1 (no)
WO (1) WO2006085175A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8231573B2 (en) 2005-02-01 2012-07-31 Intelliject, Inc. Medicament delivery device having an electronic circuit system
US8206360B2 (en) 2005-02-01 2012-06-26 Intelliject, Inc. Devices, systems and methods for medicament delivery
US9022980B2 (en) 2005-02-01 2015-05-05 Kaleo, Inc. Medical injector simulation device
CA2762072C (en) 2005-02-01 2017-08-29 Intelliject, Inc. Devices, systems, and methods for medicament delivery
US8361026B2 (en) 2005-02-01 2013-01-29 Intelliject, Inc. Apparatus and methods for self-administration of vaccines and other medicaments
EP2125075A2 (en) 2007-01-22 2009-12-02 Intelliject, Inc. Medical injector with compliance tracking and monitoring
USD994111S1 (en) 2008-05-12 2023-08-01 Kaleo, Inc. Medicament delivery device cover
DE202009003009U1 (de) * 2009-03-03 2009-07-30 Dieter Hölzle Technik-Projekte GmbH Injektionsvorrichtung mit Injektionsvolumeneinstellung
US8627816B2 (en) 2011-02-28 2014-01-14 Intelliject, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US9084849B2 (en) 2011-01-26 2015-07-21 Kaleo, Inc. Medicament delivery devices for administration of a medicament within a prefilled syringe
US8939943B2 (en) 2011-01-26 2015-01-27 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
MX365847B (es) 2013-10-25 2019-06-17 Ares Trading Sa Un sistema de cuidados para el paciente que informa el cumplimiento del regimen de tratamiento.
EP2894581A1 (en) 2014-01-13 2015-07-15 Ares Trading S.A. Medical device connection station
EP2894540A1 (en) 2014-01-13 2015-07-15 Ares Trading S.A. Medical device connection station
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone
US9919096B2 (en) * 2014-08-26 2018-03-20 Bigfoot Biomedical, Inc. Infusion pump system and method
AU2015388462A1 (en) 2015-03-24 2017-09-21 Ares Trading S.A. Patient care system
US20170136144A1 (en) 2015-11-12 2017-05-18 John C. Herr Compositions and methods for vas-occlusive contraception
US12383421B2 (en) 2017-01-05 2025-08-12 Contraline, Inc. Contraceptive devices
AU2019380413B2 (en) 2018-11-13 2025-04-17 Contraline, Inc. Systems and methods for delivering biomaterials

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3824217C2 (de) 1988-07-16 2002-10-10 Novo Nordisk As Elektronische Zusatzeinrichtung für medizinische Spritzen
JP3108502B2 (ja) * 1992-01-28 2000-11-13 テルモ株式会社 薬剤定量分与器
CA2129284C (en) * 1993-11-24 1999-03-09 Kenneth J. Niehoff Controlling plunger drives for fluid injection in animals
IL127586A0 (en) * 1996-07-05 1999-10-28 Novo Nordisk As Dose setting device
US6423035B1 (en) * 1999-06-18 2002-07-23 Animas Corporation Infusion pump with a sealed drive mechanism and improved method of occlusion detection
AU7839900A (en) * 1999-09-29 2001-04-30 Sterling Medivations, Inc. Reusable medication delivery device
US7500959B2 (en) * 2000-10-05 2009-03-10 Novo Nordisk A/S Medication delivery system with improved dose accuracy
IL156245A0 (en) * 2000-12-22 2004-01-04 Dca Design Int Ltd Drive mechanism for an injection device
JP3845857B2 (ja) * 2001-03-15 2006-11-15 ニプロ株式会社 簡易薬液注入器
GB0107609D0 (en) * 2001-03-27 2001-05-16 Dca Design Int Ltd Improvements in and relating to an injection device
ATE355093T1 (de) * 2001-05-16 2006-03-15 Lilly Co Eli Arzneimitteleinspritzvorrichtung mit rückstellung erleichternder antriebsanordnung
US7264148B2 (en) * 2001-09-12 2007-09-04 Terumo Kabushiki Kaisha Drug container and drug infusion device comprising the same
JP2004261274A (ja) * 2003-02-28 2004-09-24 Matsushita Electric Ind Co Ltd 注射装置
DK2298391T3 (da) 2004-02-18 2012-05-14 Ares Trading Sa Bærbar, elektronisk injektionsindretning til injektion af flydende lægemiddel
US7966051B2 (en) * 2005-01-11 2011-06-21 Olympus Corporation Fluorescent agent concentration measuring apparatus, dose control apparatus, administration system, fluorescent agent concentration measuring method, and dose control method

Also Published As

Publication number Publication date
US8137304B2 (en) 2012-03-20
CA2596921C (en) 2013-10-15
ES2322716T3 (es) 2009-06-25
AU2006213538B2 (en) 2011-04-14
CA2596921A1 (en) 2006-08-17
RS50983B (sr) 2010-10-31
EP1690560A1 (en) 2006-08-16
US20090318878A1 (en) 2009-12-24
HRP20090183T1 (hr) 2009-07-31
DE602006005810D1 (de) 2009-04-30
ATE425782T1 (de) 2009-04-15
HK1115078A1 (en) 2008-11-21
SI1885413T1 (sl) 2009-08-31
AU2006213538A1 (en) 2006-08-17
CY1109152T1 (el) 2014-07-02
JP2008529634A (ja) 2008-08-07
EP1885413A1 (en) 2008-02-13
WO2006085175A1 (en) 2006-08-17
EP1885413B1 (en) 2009-03-18
JP4971192B2 (ja) 2012-07-11
PL1885413T3 (pl) 2009-08-31
DK1885413T3 (da) 2009-06-08
PT1885413E (pt) 2009-04-07
ME01094B (me) 2013-03-20
IL184878A0 (en) 2007-12-03

Similar Documents

Publication Publication Date Title
NO20074035L (no) Medisinleveringssystem
Seyedmousavi et al. The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside
MX343867B (es) Paquete de dosificacion unitaria y metodos para administrar medicaciones de perdida de peso.
Magni et al. A mathematical model to study the effects of drugs administration on tumor growth dynamics
SA519401163B1 (ar) نظام وطريقة لعلاج طبي متحكم فيه
Gradman Strategies for combination therapy in hypertension
WO2005117697A3 (en) Unified indigestion package and process for patient compliance with prescribed medication regimen
IL184878A0 (en) Medication delivery device
MX2007005179A (es) Formas de dosificacion.
ATE551596T1 (de) Arzneistoffauthentisierung
Zhang et al. Effects and safety of a novel oral potassium-lowering drug-sodium zirconium cyclosilicate for the treatment of hyperkalemia: a systematic review and meta-analysis
FI3119431T3 (fi) Kalsitoniinigeeniin liittyvää peptidiä vastaan suunnattuja antagonisti-vasta-aineita ja menetelmiä niiden käyttämiseksi
DE50307435D1 (de) Gegen missbrauch gesicherte darreichungsform
NZ593512A (en) Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
Kizilirmak et al. The efficacy and safety of triple vs dual combination of angiotensin II receptor blocker and calcium channel blocker and diuretic: a systematic review and meta‐analysis
EP4191245A3 (en) Identifying patient response to s1p receptor modulator administration
Moreau et al. Efficacy of daratumumab, lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone for relapsed or refractory multiple myeloma among patients with 1 to 3 prior lines of therapy based on previous treatment exposure: updated analysis of pollux
Olivella et al. Role of vericiguat in management of patients with heart failure with reduced ejection fraction after worsening episode
GB2458614A (en) Method and system for remotely administering a diuretic therapy
Tefferi et al. Pomalidomide therapy in anemic patients with myelofibrosis: results from a phase-2 randomized multicenter study
Vogt the renoprotective effects of sulodexide
Kostik et al. A87: Different Tocilizumab Therapeutic Protocols and Possibility Achieving Tocilizumab‐Off Remission in Systemic Juvenile Idiopathic Arthritis
Deedwania et al. Does Response of RAS Blockade on Serum K+ Levels Influence Its Glycemic‐Mitigating Response When Combined With Hydrochlorothiazide?
Huard Ribavirin/sofosbuvir
Krishnan A modelling framework for elucidating the interplay between drug transport and cellular effects in tumours

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application